Thursday, April 25, 2013

• Which One Should Investors Buy: The Ex-Parent or the Spin-off?at Motley Fool (Thu, Apr 25)

Wednesday, April 24, 2013

• Is Merck a Cash King?at Motley Fool (Wed, Apr 24)
• 5 Health Care Stocks On The Riseat TheStreet (Wed, Apr 24)
• Billionaire Frost’s Opko to Buy Prolor in $480 Million Dealat Bloomberg (Wed, Apr 24)
• Should You Buy Stock in Amgen After the Q1 Results Pullback?at Motley Fool (Wed, Apr 24)
• Zacks Sell List Highlights: AngloGold Ashanti, Orient-Express Hotels, Teva Pharmaceutical Industries and Cytec IndustriesZacks (Wed, Apr 24)
• Teva Establishes Global Specialty Medicines GroupBusiness Wire (Wed, Apr 24)

Tuesday, April 23, 2013

• An Undervalued Pharmaceutical Company With Remarkable Resultsat Seeking Alpha (Tue, Apr 23)
• Does Teva Have a Silver Lining?at Motley Fool (Tue, Apr 23)
• More Than Half of Nasal Allergy Sufferers Experience Sleep Issues, Yet Many Fail to Adequately Prepare in Advance of Peak Allergy SeasonsPR Newswire (Tue, Apr 23)
• Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402Business Wire (Tue, Apr 23)

Monday, April 22, 2013

• Teva Pharmaceuticals: Will the Transition Be Effective?at Motley Fool (Mon, Apr 22)
• Teva Pharmaceutical Industries Becomes Oversold (TEVA)at TheStreet (Mon, Apr 22)

Sunday, April 21, 2013

• Finding Stocks to Help You Retire Richat Motley Fool (Sun, Apr 21)

Saturday, April 20, 2013

• Can Amgen's Earnings Keep Its Stock Soaring?at Motley Fool (Sat, Apr 20)
• Israel - A Standout Among The OECD Economiesat Seeking Alpha (Sat, Apr 20)

Thursday, April 18, 2013

• Data on Teva's MilprosaZacks (Thu, Apr 18)
• Will Dividend Growth for This Dividend King Start Slowing?at Motley Fool (Thu, Apr 18)
• Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA)at TheStreet (Thu, Apr 18)
• Teva More Undervalued Than Mylan, Looks Towards Technologyat Seeking Alpha (Thu, Apr 18)

Wednesday, April 17, 2013

• A Few Reasons Why You Should Stay Away From This Pharma Companyat Motley Fool (Wed, Apr 17)
• Teva Presented New Data from Phase III Clinical Trial of Milprosa™ (Progesterone) Vaginal Ring at the 61st Annual Meeting of the Pacific Coast Reproductive SocietyBusiness Wire (Wed, Apr 17)

Tuesday, April 16, 2013

• Apolo Anton Ohno And Teva Respiratory Announce Finalists In National EIB All Stars™ ContestPR Newswire (Tue, Apr 16)
• Drug makers refusing to supply drugs to generic competitors, NY Times saystheflyonthewall.com (Tue, Apr 16)

Monday, April 15, 2013

• Investing in Pharmaceuticals? Ask Phillip Frostat Motley Fool (Mon, Apr 15)

Add TEVA News to My Yahoo!